SYNERGISTIC ANTITUMOR ACTIVITIES OF DOCETAXEL AND OCTREOTIDE ASSOCIATED WITH APOPTOTIC-UPREGULATION IN CASTRATION-RESISTANT PROSTATE CANCER.

Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer.

Androgen deprivation therapy has become the fist-line treatment of metastatic prostate cancer; however, progression to castrate resistance disease occurs in the majority of patients.Thus, there is an urgent need for improvements in therapy for castration-resistant prostate cancer.The aims of the present study were to determine the efficacy somatost

read more